GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » Deferred Tax

Cresco Labs (XCNQ:CL) Deferred Tax : C$-44 Mil (TTM As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Cresco Labs's change in deferred tax for the three months ended in Dec. 2023 was C$-10 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was C$-44 Mil.

Cresco Labs Deferred Tax Historical Data

The historical data trend for Cresco Labs's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Deferred Tax Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.55 -14.29 -44.71 -6.31 -43.82

Cresco Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.98 -1.35 0.43 -33.66 -9.56

Cresco Labs Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-44 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Deferred Tax Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Cresco Labs (XCNQ:CL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » Deferred Tax
Comparable Companies
TSX:DHT.U NEOE:GLAS.A.U TSX:WEED TSX:TSND TSX:GUD TSX:CRON TSX:ACB XCNQ:AAWH.U XCNQ:AYR.A TSX:OGI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
CRLBF:USA 6CQ:Germany
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Website
https://www.crescolabs.com
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.